11.71 +0.31 (2.68%)
NKTR
Stock Details
Last Trade:11.71 Change:+0.31 (2.68%) Prev Close:11.40 Open: 11.56 Days Range:11.40 – 11.76 52 Week Range: 4.00 - 12.28 Volume:611817 P/E: N/AEPS:-0.19
View AllRecent Alerts 02/10/10
Recent Alert on 01/19/10 at 12:28pm
Brean Murray Reiterates a 'Buy' on Nektar Therapeutics (NKTR)
Brean Murray Reiterates a 'Buy' on Nektar Therapeutics (NKTR)
Brean Murray reiterates a 'Buy' on Nektar Therapeutics (Nasdaq: NKTR), raises price target from $15 to $12. Brean analyst says, "After a more thorough review of the initial Phase 2 NKTR-102 results and Phase 1 pharmacokinetic data for NKTR-105, we... Read More
Recent Alert on 01/12/10 at 9:17am
Nektar Therapeutics (NKTR) Announces Positive Results from NKTR-102 Phase 2
Nektar Therapeutics (NKTR) Announces Positive Results from NKTR-102 Phase 2
Recent Alert on 01/12/10 at 9:17am
Nektar Therapeutics (NKTR) Announces Positive Results from NKTR-102 Phase 2
Nektar Therapeutics (NKTR) Announces Positive Results from NKTR-102 Phase 2
Recent Alert on 12/07/09 at 3:02pm
Wedbush Maintains an 'Outperform' on Nektar Therapeutics (NKTR), Recent Marketing Trip Focused on Upcoming Ovarian Cancer Data
Wedbush Maintains an 'Outperform' on Nektar Therapeutics (NKTR), Recent Marketing Trip Focused on Upcoming Ovarian Cancer Data
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/09/10 at 5:26pm
Form SC 13G/A NEKTAR THERAPEUTICS Filed by: BIOTECHNOLOGY VALUE FUND L P
Form SC 13G/A NEKTAR THERAPEUTICS Filed by: BIOTECHNOLOGY VALUE FUND L P
SEC Filing on 02/08/10 at 3:45pm
Form SC 13G/A NEKTAR THERAPEUTICS Filed by: COLUMBIA WANGER ASSET MANAGEMENT LP
Form SC 13G/A NEKTAR THERAPEUTICS Filed by: COLUMBIA WANGER ASSET MANAGEMENT LP